FRLI Stock Overview
Frélii, Inc. provides personalized subscription based nutrition and wellness programs.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Frélii, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.04 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 9,900.00% |
3 Month Change | n/a |
1 Year Change | 9,900.00% |
3 Year Change | -99.43% |
5 Year Change | -100.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
FRLI | US Healthcare Services | US Market | |
---|---|---|---|
7D | 0% | -6.1% | -3.7% |
1Y | 9,900.0% | -11.9% | 20.2% |
Return vs Industry: FRLI exceeded the US Healthcare Services industry which returned -11.9% over the past year.
Return vs Market: FRLI exceeded the US Market which returned 20.2% over the past year.
Price Volatility
FRLI volatility | |
---|---|
FRLI Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 9.9% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: FRLI's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine FRLI's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Ian Jenkins | www.frelii.com |
Frélii, Inc. provides personalized subscription based nutrition and wellness programs. The company offers health assessments and nutrition plans based on genetic data, physiology, environmental and lifestyle factors, and lab diagnostics through its frelii.com Web platform. Its platform also provides lab diagnostics kits, compounding pharmacy products, and nutritional and vitamin supplements.
Frélii, Inc. Fundamentals Summary
FRLI fundamental statistics | |
---|---|
Market cap | US$5.89k |
Earnings (TTM) | -US$4.51m |
Revenue (TTM) | US$81.96k |
0.0x
P/S Ratio0.0x
P/E RatioIs FRLI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
FRLI income statement (TTM) | |
---|---|
Revenue | US$81.96k |
Cost of Revenue | US$21.28k |
Gross Profit | US$60.68k |
Other Expenses | US$4.57m |
Earnings | -US$4.51m |
Last Reported Earnings
Sep 30, 2019
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did FRLI perform over the long term?
See historical performance and comparison